1682O_PRFinal results of a phase II/III, randomized, double blind, placebo-controlled study to investigate the efficacy of a high potency multistrain probiotic, on chemotherapy induced diarrhea in cancer patients receiving fluropyrimidines and/or irinotecan-based therapy. (23rd October 2018) - Sharma, A; Chaudhary, S P; Raina, V; Shukla, N K; Sreenivas, V; Prakash, S; Priyatma, P; Bharti, S